跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 宥欣
教授
藥學系
電話
(02) 28267000 #7932
電子郵件
ylhsin
ym.edu
tw
網站
https://bps.nycu.edu.tw/zh/faculty-members/%E6%9E%97%E5%AE%A5%E6%AC%A3-yu-hsin-lin/
h-index
h10-index
h5-index
4819
引文
36
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
837
引文
14
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
171
引文
8
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2001
2024
每年研究成果
概覽
指紋
網路
研究成果
(67)
類似的個人檔案
(4)
指紋
查看啟用 Yu-Hsin Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Nanoparticles
58%
Chitosan
31%
Helicobacter Pylori (H. pylori)
26%
Poly-γ-glutamic Acid (γ-PGA)
20%
Epigallocatechin-3-gallate
19%
Targeted Nanoparticles
17%
Fucoidan
17%
Epigallocatechin Gallate
17%
Oral Delivery
16%
Wound Healing
15%
Activated Carbon Fiber
13%
Cytolethal Distending Toxin
12%
Helicobacter Pylori Eradication
12%
Diabetes
10%
Genipin
10%
Gastric Cancer
10%
Gelatin
10%
Gastric Cancer Surgery
9%
Campylobacter Jejuni
9%
Heparin Nanoparticles
9%
Insulin
9%
Oral Insulin Delivery
9%
PH-sensitive Hydrogel
9%
Penicillin Acylase
9%
Escherichia Coli
9%
Gastric Cancer Cells
9%
Polyethylene Glycol
9%
Hyaluronic Acid
8%
Nanoparticle Delivery System
8%
CdtB
8%
Amoxicillin
8%
Alginate
8%
Helicobacter Pylori Infection
8%
Inflammation
8%
Doxorubicin
8%
Heparin
7%
Fucose
7%
Protein Drug
7%
Cancer Therapy
7%
Cancer Treatment
7%
PH-responsive
7%
Prostate Tumor
7%
Prostate Cancer
7%
Natural Compounds
7%
Prostate Cancer Cells
7%
Cluster of Differentiation 44 (CD44)
7%
Gastric Tumor
7%
Cancer Cells
6%
Novel Nanoparticles
6%
P-selectin
6%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Chitosan
43%
Epigallocatechin Gallate
27%
Helicobacter Pylori
27%
Malignant Neoplasm
23%
Gelatin
21%
Abdominal Cancer
20%
Fucoidan
20%
Neoplasm
20%
Polyglutamic Acid
16%
Heparin
16%
Doxorubicin
15%
Wound Healing
13%
Prostate Cancer
13%
Cytolethal Distending Toxin
12%
Arginine
11%
Hyaluronic Acid
11%
Genipin
10%
Inflammation
9%
Campylobacter Jejuni
9%
Alginic Acid
9%
Triple Negative Breast Cancer
9%
Amoxicillin
8%
Combination Therapy
8%
Macrogol
7%
Prostate Tumor
6%
Natural Product
6%
Fucose
6%
P-Selectin
6%
Wound Dressings
6%
Chitosan Derivative
6%
Wound
6%
Berberine
6%
Curcumin
6%
Synergistic Therapy
6%
Tumor Model
6%
2,5-Dimethoxy-4-iodoamphetamine
6%
Chemotherapy
6%
Infection
5%
Stomach Tumor
5%
Helicobacter Infection
5%